Our results show that the addition of low doses of IFN-α substantially enhanced the expression of CD40high, CD86high, HLA class IIhigh in DCs generated from adherent cultures of monocytes obtained from blood and lymph nodes of patients with operable breast cancer. Here, IFNA1 is linked to breast cancer.